Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients-Reference-Cited by-同舟云学术

Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients

Published:2010-04 Issue:4 Volume:69 Page:346-357
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Sommerer Claudia,Müller-Krebs Sandra,Schaier Matthias,Glander Petra,Budde Klemens,Schwenger Vedat,Mikus Gerd,Zeier Martin

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2009.03612.x/fullpdf

Reference40 articles.

1. Placebo-controlled study of mycophenolate mofetil combined with ciclosporin and corticosteroids for prevention of acute rejection;Grinyo;Lancet,1995

2. A blinded, randomised clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation;Keown;Transplantation,1996

3. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group;Sollinger;Transplantation,1995

4. Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration;Meier-Kriesche;Transplantation,2003

5. Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration;Bullingham;J Clin Pharmacol,1996

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Better Rejection‐Free Survival at Three Years in Kidney Transplant Recipients With Model‐Informed Precision Dosing of Mycophenolate Mofetil;Clinical Pharmacology & Therapeutics;2024-02-19

2. The Impact of Inflammation on the In Vivo Activity of the Renal Transporters OAT1/3 in Pregnant Women Diagnosed with Acute Pyelonephritis;Pharmaceutics;2023-10-05

3. Immune Monitoring of Mycophenolate Mofetil Activity in Healthy Volunteers Using Ex Vivo T Cell Function Assays;Pharmaceutics;2023-05-31

4. Mycophenolate Mofetil Dose Adjustment in Pediatric Kidney Transplant Recipients;Therapeutic Drug Monitoring;2023-02-22

5. Influence of Calcineurin Inhibitors and Genetic Polymorphism of Transporters on Enterohepatic Circulation and Exposure of Mycophenolic Acid in Chinese Adult Renal Allograft Recipients;The Journal of Clinical Pharmacology;2022-12-29